Long-acting contraception in adolescents and young women with type 1 and type 2 diabetes.
Abril SalinasPaulina M MerinoFranco GiraudoEthel CodnerPublished in: Pediatric diabetes (2020)
Adolescent pregnancy is a major public health problem worldwide. Adolescents living with diabetes are not aware of the risks of unplanned pregnancy and the high rate of fetal and maternal complications when gestation occurs in women with significant hyperglycemia. These data highlight the significance of pregnancy prevention in young women with diabetes. Long-acting reversible contraceptives (LARCs), which include subdermal progestin implants and hormonal and nonhormonal intrauterine devices (IUDs), have been recommended by the American College of Obstetricians Gynecologists and the American Academy of Pediatrics as a first-line contraceptive option for adolescents and young women. This article reviews LARC options for adolescents and young women with type 1 (T1D) and type 2 (T2D) diabetes as well as the possible complications and side effects.
Keyphrases
- young adults
- type diabetes
- glycemic control
- physical activity
- public health
- cardiovascular disease
- pregnancy outcomes
- preterm birth
- risk factors
- mental health
- randomized controlled trial
- insulin resistance
- electronic health record
- preterm infants
- pregnant women
- middle aged
- climate change
- metabolic syndrome
- big data
- risk assessment
- polycystic ovary syndrome